| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.06▲ | 3.06▲ | 3.06▲ | 2.91▲ | 2.82▲ |
| MA10 | 3.06▲ | 3.07▲ | 3.02▲ | 2.94▲ | 2.31▲ |
| MA20 | 3.06▲ | 3.00▲ | 2.95▲ | 2.95▲ | 1.94▲ |
| MA50 | 3.06▲ | 2.92▲ | 2.96▲ | 2.27▲ | 1.74▲ |
| MA100 | 3.02▲ | 2.95▲ | 2.96▲ | 1.91▲ | 2.56▲ |
| MA200 | 2.95▲ | 2.98▲ | 2.63▲ | 1.76▲ | 4.92▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | 0.002▲ | 0.019▲ | -0.041▼ | 0.161▲ |
| RSI | 64.931▲ | 63.536▲ | 62.496▲ | 60.583▲ | 73.273▲ |
| STOCH | 33.333 | 41.700 | 73.930 | 44.545 | 78.830 |
| WILL %R | 0.000▲ | -21.212▲ | -21.212▲ | -34.545 | -23.500▲ |
| CCI | 179.310▲ | 40.837 | 77.246 | 39.224 | 120.101▲ |
|
Thursday, February 26, 2026 09:30 AM
ROCKVILLE, MD, Feb. 26, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, ...
|
|
Monday, February 23, 2026 03:14 PM
ROCKVILLE, MD, Feb. 23, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on developing innovative antibody-based therapeutics for the ...
|
|
Tuesday, November 25, 2025 08:04 AM
ROCKVILLE, MD, Nov. 25, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 02/04/26 | 2.83 | 3.16 | 2.83 | 3.07 | 713,840 |
| 01/04/26 | 2.89 | 2.96 | 2.85 | 2.90 | 425,210 |
| 31/03/26 | 2.84 | 2.965 | 2.82 | 2.89 | 281,699 |
| 30/03/26 | 2.95 | 2.95 | 2.73 | 2.76 | 568,229 |
| 27/03/26 | 3.16 | 3.185 | 2.85 | 2.93 | 953,996 |
| 26/03/26 | 3.14 | 3.26 | 3.03 | 3.18 | 883,282 |
| 25/03/26 | 2.78 | 3.21 | 2.78 | 3.17 | 1,659,010 |
| 24/03/26 | 2.88 | 2.88 | 2.71 | 2.73 | 663,855 |
| 23/03/26 | 2.86 | 3.01 | 2.73 | 2.92 | 797,095 |
| 20/03/26 | 2.87 | 2.93 | 2.805 | 2.86 | 644,158 |
|
|
||||
|
|
||||
|
|